140 related articles for article (PubMed ID: 18684427)
1. Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients.
Kornhauser C; Garcia-Ramirez JR; Wrobel K; Pérez-Luque EL; Garay-Sevilla ME; Wrobel K
Prim Care Diabetes; 2008 Jun; 2(2):81-5. PubMed ID: 18684427
[TBL] [Abstract][Full Text] [Related]
2. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
[TBL] [Abstract][Full Text] [Related]
3. Association between plasma selenium and glutathione peroxidase levels and severity of diabetic nephropathy in patients with type two diabetes mellitus.
Sedighi O; Makhlough A; Shokrzadeh M; Hoorshad S
Nephrourol Mon; 2014 Sep; 6(5):e21355. PubMed ID: 25695036
[TBL] [Abstract][Full Text] [Related]
4. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between increase of oxidative stress and microalbuminuria in type-1 diabetic patients].
Artenie A; Artenie R; Ungureanu D; Covic A
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):777-81. PubMed ID: 16004216
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
8. Effect of selenium on human myocardial glutathione peroxidase gene expression.
Liu D; Liu S; Huang Y; Liu Y; Zhang Z; Han L
Chin Med J (Engl); 2000 Sep; 113(9):771-5. PubMed ID: 11776067
[TBL] [Abstract][Full Text] [Related]
9. Enhanced testicular antioxidant capacity in streptozotocin-induced diabetic rats: protective role of vitamins C and E and selenium.
Naziroğlu M
Biol Trace Elem Res; 2003 Jul; 94(1):61-72. PubMed ID: 12907828
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma glutathione peroxidase concentration in acute severe asthma: comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde.
Jacobson GA; Yee KC; Ng CH
Scand J Clin Lab Invest; 2007; 67(4):423-30. PubMed ID: 17558897
[TBL] [Abstract][Full Text] [Related]
11. Plasma antioxidants and type 2 diabetes mellitus.
Palanduz S; Ademoğlu E; Gökkuşu C; Tamer S
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):309-18. PubMed ID: 12889514
[TBL] [Abstract][Full Text] [Related]
12. Protective role of intraperitoneally administered vitamin E and selenium on the antioxidative defense mechanisms in rats with diabetes induced by streptozotocin.
Naziroğlu M; Cay M
Biol Trace Elem Res; 2001 Feb; 79(2):149-59. PubMed ID: 11330521
[TBL] [Abstract][Full Text] [Related]
13. Plasma selenoproteins concentrations in type 2 diabetes mellitus--a pilot study.
Roman M; Lapolla A; Jitaru P; Sechi A; Cosma C; Cozzi G; Cescon P; Barbante C
Transl Res; 2010 Oct; 156(4):242-50. PubMed ID: 20875901
[TBL] [Abstract][Full Text] [Related]
14. [Advanced oxidation protein products in diabetic nephropathy patients and its relation with superoxide dismutase, glutathione peroxidase, neopterin].
Wu ZX; Xue YM; Li CZ; Guan MP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):704-7. PubMed ID: 16708815
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
16. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
17. Selenium and glycogen levels in diabetic patients.
Kljai K; Runje R
Biol Trace Elem Res; 2001 Dec; 83(3):223-9. PubMed ID: 11794514
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant status in patients with lichen planus.
Barikbin B; Yousefi M; Rahimi H; Hedayati M; Razavi SM; Lotfi S
Clin Exp Dermatol; 2011 Dec; 36(8):851-4. PubMed ID: 21883397
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
